This clinical profile examines the molecular pharmacology, mechanism of action, tissue-specific effects, dosing parameters, and current evidence supporting BPC-157's potential therapeutic applications
Persistent hunger despite adequate dosing : If you continue to experience significant hunger after reaching a stable maintenance dose for at least 12 weeks, discuss this with your healthcare provider
GHK-Cu (copper tripeptide-1) is a naturally occurring copper-binding tripeptide (Gly-His-Lys) first isolated from human plasma by biochemist Loren Pickart in 1973
It also appears to help to prime the cardiac stem cells for tissue regeneration through direct differentiation, secretion of protective and cardiomyogenic factors, and/or their fusion with injured cardiomyocytes . It further appears to mitigate cases of cardiac damage due to diabetes in mice
Body Rejuvenation states that certain prescribed peptide products may be shipped to the patient after consultation with a licensed physician